Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22993| Title: | Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Camptothecin/adverse effects/*analogs & derivatives/therapeutic use,Carcinoma, Small Cell/*drug therapy/pathology,Cisplatin/adverse effects/*therapeutic use,Disease Progression,Dose-Response Relationship, Drug,Drug Therapy, Combination,Etoposide/adverse effects/*therapeutic use,Female,Humans,Lung Neoplasms/*drug therapy/pathology,Male,Middle Aged,Survival Rate |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/22993 |
| ISSN: | 0169-5002 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/17698241 http://ac.els-cdn.com/S016950020700400X/1-s2.0-S016950020700400X-main.pdf?_tid=6fda7be28bdd84412d029e4e6eb44bf7&acdnat=1333703544_dd61f8cad53cb795221b0d9e25bb4862 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pectasides-2007-Combination chemothe.pdf | 180.03 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
